Authors: KREITLER S BARAK F KOVNER F INBAR M

Citation: S. Kreitler et al., ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER PATIENTS - PATIENTS EXPECTATIONS AND PHYSICIANS ATTITUDES, European journal of cancer, 34, 1998, pp. 282-282

Authors: BARAK F SUSKOLNE V CHEN R SCHARF S PELED R

Citation: F. Barak et al., FACTORS ENCOURAGING OR DISCOURAGING WOMEN UNDERGO CLINICAL BREAST EXAMINATION, European journal of cancer, 33, 1997, pp. 578-578

Authors: PAVLOTSKY A EIDELMAN A BARAK F WALACH N HORN Y

Citation: A. Pavlotsky et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH SUPERFICIAL TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER TREATED BY INTRAVESICAL MITOMYCIN-C, Journal of surgical oncology, 60(3), 1995, pp. 191-195

Authors: HORN Y WALACH N PAVLOTSKY A BARAK F BENZ C

Citation: Y. Horn et al., RANDOMIZED STUDY COMPARING CHEMOTHERAPY WITH AND WITHOUT ESTROGEN PRIMING IN ADVANCED BREAST-CANCER, International journal of oncology, 4(2), 1994, pp. 499-501